Managing acid reflux involves lifestyle adjustments to reduce symptoms and prevent discomfort. Strengthening the lower esophageal sphincter can help prevent acid from rising into the esophagus. Avoiding smoking,…
Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum, causing symptoms like abdominal pain, bloody diarrhea, rectal urgency, and fatigue. Sanjay Murthy, MD,…
NEW YORK (Reuters Health) – Contraception, or different reproductive patterns related to contraceptive methods, may affect the risk of some types of cancer, according to findings from the…
NEW YORK (Reuters Health) – Patients with type 2 diabetes have an almost three-fold higher risk of acute pancreatitis and two-fold greater risk of biliary disease compared with…
NEW YORK (Reuters Health) Women with long-standing hypothyroidism are at increased risk of hepatocellular carcinoma, the results of a case-control study suggest. By contrast, hypothyroidism is not significantly…
NEW YORK (Reuters Health) – As a treatment for symptomatic hemorrhoids, circular stapled anopexy is associated with less pain and has higher patient acceptability than does excisional hemorrhoidectomy,…
NEW YORK (Reuters Health) – Although folate fortification of foods may reduce the rate of neural tube defects in target populations, new research from Chile suggests that it…
NEW YORK (Reuters Health) – Surgically induced weight loss is cost-effective relative to conventional therapy for the management of type 2 diabetes in obese patients, both in the…
NEW YORK (Reuters Health) For patients with epidermal growth factor (EGF) receptor-positive colorectal cancer and unresectable metastases, adding cetuximab to first-line treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)…
NEW YORK (Reuters Health) – Long-term treatment with infliximab has a good safety profile and significantly reduces hospitalization and surgery rates in patients with Crohn’s disease, according to…
NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows.…
NEW YORK (Reuters Health) – As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and –negative patients, according…
